[Clinical practice guideline for the management of Hunter syndrome. Hunter España working group]

Med Clin (Barc). 2013 Nov 16;141(10):453.e1-13. doi: 10.1016/j.medcli.2013.07.010. Epub 2013 Sep 21.
[Article in Spanish]
No abstract available

Keywords: Mucopolisacaridosis; Síndrome de Hunter; Tratamiento enzimático sustitutivo.

Publication types

  • Consensus Development Conference
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Allografts
  • Chromosomes, Human, X / genetics
  • Diagnosis, Differential
  • Diagnostic Imaging
  • Disease Progression
  • Dysostoses / diagnosis
  • Enzyme Replacement Therapy / adverse effects
  • Enzyme Replacement Therapy / methods
  • Evidence-Based Medicine
  • Female
  • Genetic Carrier Screening
  • Genetic Counseling
  • Glycosaminoglycans / metabolism
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Iduronate Sulfatase / administration & dosage
  • Iduronate Sulfatase / adverse effects
  • Iduronate Sulfatase / analysis
  • Iduronate Sulfatase / genetics
  • Iduronate Sulfatase / therapeutic use
  • Interdisciplinary Communication
  • Lysosomal Storage Diseases / diagnosis
  • Lysosomes / metabolism
  • Male
  • Medical History Taking / standards
  • Mucopolysaccharidosis II / diagnosis
  • Mucopolysaccharidosis II / drug therapy
  • Mucopolysaccharidosis II / genetics
  • Mucopolysaccharidosis II / surgery
  • Mucopolysaccharidosis II / therapy*
  • Neurologic Examination
  • Physical Examination
  • Preimplantation Diagnosis
  • Recombinant Proteins / therapeutic use
  • Symptom Assessment

Substances

  • Glycosaminoglycans
  • Recombinant Proteins
  • Iduronate Sulfatase